Patents by Inventor Kristian Roos

Kristian Roos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10596244
    Abstract: A pharmaceutical preparation for prophylaxis against and treatment of Staphylococcus induced infections or condi-tions in humans and animals, is disclosed, wherein it comprises a combination of a) one or more viable ?-Streptococcus strains chosen from the group consisting of the Streptococcus sanguis JI strains having the accession numbers NCTMB 40104, NCTMB 40105, NCIMB 40106, and NCIMB 40873, the Streptococcus mitis strains having the accession numbers NCIMB 40107, and NCIMB 40874, the Streptococcus oralis strains having the accession numbers NCIMB 40875 and NCIMB 40876, the Streptococcus lactis strain LIA having the accession number NCIMB 40157, and one or more variants thereof having the same or essentially similar effect; and b) one or more viable Lactobacillus strains chosen from the group consisting of the Lactobacillus rhamnosus strain LB2 I having the accession number NCIMB 40564, the Lactobacillus plantamm strain LB3 having the accession number DSM 17852, and the Lactobacillus plantarwn strain LB7 h
    Type: Grant
    Filed: October 8, 2015
    Date of Patent: March 24, 2020
    Assignee: WINCLOVE HOLDING B.V.
    Inventors: Kristian Roos, Eva Grahn HÃ¥kansson
  • Publication number: 20160089428
    Abstract: A pharmaceutical preparation for prophylaxis against and treatment ofStaphylococcus induced infections or conditions in humans and animals, is disclosed, wherein it comprises a combination of a) one or more viable ?-Streptococcus strains chosen from the group consisting of the Streptococcus sanguis II strains having the accession numbers NCIMB 40104, NCIMB 40105, NCIMB 40106, and NCIMB 40873, the Streptococcus mitis strains having the accession numbers NCIMB 40107, and NCIMB 40874, the Streptococcus oralis strains having the accession numbers NCIMB 40875 and NCIMB 40876, the Streptococcus lactis strain L1A having the accession number NCIMB 40157, and one or more variants thereof having the same or essentially , similar effect; and b) one or more viable Lactobacillus strains chosen from the group consisting of the Lactobacillus rhamnosus strain LB21 having the accession number NCIMB 40564, the Lactobacillus plantarum strain LB3 having the accession number N DSM 17852, and the Lactobacillus plantarum strain LB7
    Type: Application
    Filed: October 8, 2015
    Publication date: March 31, 2016
    Inventors: Kristian ROOS, Eva Grahn HÃ…KANSSON
  • Publication number: 20110256179
    Abstract: A pharmaceutical preparation for prophylaxis against and treatment of Staphylococcus induced infections or conditions in humans and animals, is disclosed, wherein it comprises a combination of a) one or more viable ?-Streptococcus strains chosen from the group consisting of the Streptococcus sanguis II strains having the accession numbers NCIMB 40104, NCIMB 40105, NCIMB 40106, and NCIMB 40873, the Streptococcus mitis strains having the accession numbers NCIMB 40107, and NCIMB 40874, the Streptococcus oralis strains having the accession numbers NCIMB 40875 and NCIMB 40876, the Streptococcus lactis strain L1A having the accession number NCIMB 40157, and one or more variants thereof having the same or essentially similar effect; and b) one or more viable Lactobacillus strains chosen from the group consisting of the Lactobacillus rhamnosus strain LB21 having the accession number NCIMB 40564, the Lactobacillus plantarum strain LB3 having the accession number DSM 17852, and the Lactobacillus plantarum strain LB7 ha
    Type: Application
    Filed: November 17, 2009
    Publication date: October 20, 2011
    Applicant: Essum AB
    Inventors: Kristian Roos, Eva Grahn H?kansson